A61K 31/704 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
A61K 31/7034 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
A61P 43/00 - Drugs for specific purposes, not provided for in groups
3.
AUTOPHAGY ACTIVATOR AND COMPOSITION FOR AUTOPHAGY ACTIVATION
Provided is an autophagy activator comprising at least one of a compound represented by structural formula (1) and a compound represented by structural formula (2).
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A23F 5/24 - Extraction of coffeeCoffee extractsMaking instant coffee
A61L 33/10 - Heparin, heparinoid or derivatives thereof
A61P 43/00 - Drugs for specific purposes, not provided for in groups
Compounds 1 to 3 represented by General Formula (I) below are used as the active ingredients of the anti-metabolic syndrome agent, skin whitening agent, anti-aging agent, hair growth agent, anti-inflammatory agent, and liver function-improving agent of the present invention. The oral composition, skin cosmetic, and hair cosmetic of the present invention are compounded with compounds 1 to 3 represented by General Formula (I) below. The present invention can provide an anti-metabolic syndrome agent, a skin whitening agent, an anti-aging agent, a hair growth agent, an anti-inflammatory agent, and a liver function-improving agent that have excellent actions and effects, and can also provide an oral composition, a skin cosmetic, and a hair cosmetic that are suitable for an anti-metabolic syndrome application, a skin whitening application, an anti-aging application, a hair growth application, an anti-inflammatory application, and a liver function-improving application.
Compounds 1 to 3 represented by General Formula (I) below are used as the active ingredients of the anti-metabolic syndrome agent, skin whitening agent, anti-aging agent, hair growth agent, anti-inflammatory agent, and liver function-improving agent of the present invention. The oral composition, skin cosmetic, and hair cosmetic of the present invention are compounded with compounds 1 to 3 represented by General Formula (I) below. The present invention can provide an anti-metabolic syndrome agent, a skin whitening agent, an anti-aging agent, a hair growth agent, an anti-inflammatory agent, and a liver function-improving agent that have excellent actions and effects, and can also provide an oral composition, a skin cosmetic, and a hair cosmetic that are suitable for an anti-metabolic syndrome application, a skin whitening application, an anti-aging application, a hair growth application, an anti-inflammatory application, and a liver function-improving application.
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
6.
TYPE I COLLAGEN PRODUCTION PROMOTER, COMPOSITION FOR TYPE I COLLAGEN PRODUCTION PROMOTION, BONE STRENGTHENING AGENT, AND BONE STRENGTHENING COMPOSITION
Provided are: a type I collagen production promoter containing at least one of the compounds represented by any of structural formulae (1)-(4); and a bone strengthening agent.
This packaged beverage comprises dihydroferulic acid (A) and ascorbic acid (B) or a salt thereof, wherein the concentration of dihydroferulic acid (A) is 40 ppm or more.
The present invention uses a lactic acid bacteria fermentation product of sap of a plant of the genus Betula as an active ingredient of an anti-aging agent, hair growth agent, and anti-androgen agent. An anti-aging agent, hair growth agent, and anti-androgen agent exhibiting an excellent effect can be provided according to the present invention.
A61K 8/99 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
Provided are a myoblast proliferation promoting agent and a muscular atrophy inhibiting agent that contain a compound represented by structural formula (1).
Provided are: an anti-obesity agent containing an extract of the below-ground portion of Peucedanum Japonicum; and an anti-obesity composition containing said anti-obesity agent.
A61K 36/23 - Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
A23G 1/48 - Cocoa products, e.g. chocolateSubstitutes therefor characterised by the composition containing plants or parts thereof, e.g. fruits, seeds, extracts
Provided is a method for producing 3-phenylpropionic acid analogue compounds given by formula (I), the production method characteristically comprising a step for culturing a lactic acid bacterium from genus Weissella using a culture medium that contains at least 3 mM of a cinnamic acid analogue compound given by formula (II), wherein the lactic acid bacterium exhibits the following properties (1a) to (3a) when the lactic acid bacterium is inoculated to MRS liquid culture medium containing 3 mM 4-hydroxy-3-methoxycinnamic acid and is cultured for 24 hours at 37°C under anaerobic conditions: (1a) a turbidity of at least 1.0; (2a) a ratio for reduction to 3-(4-hydroxy-3-methoxyphenyl)propionic acid of at least 80%; and (3a) a ratio for decarboxylation to 4-vinylguaiacol of less than 5%. Also provided is a lactic acid bacterium that exhibits these properties. 3-Phenylpropionic acid analogue compounds can be efficiently produced using this method and this lactic acid bacterium.
A compound represented by formula (I) is used as an active ingredient of an AMPK activator, a motor function improving agent, a muscular endurance improving agent and a muscle atrophy preventing agent according to the present invention. The compound represented by formula (I) is added to an oral composition for AMPK activation purposes, an oral composition for motor function improvement purposes, an oral composition for muscular endurance improvement purposes, and an oral composition for muscle atrophy prevention purposes according to the present invention.
A composition containing black ginger extract including black ginger extract, and cyclodextrin. The composition containing black ginger extract includes certain 6 polymethoxyflavones (6PMF). When a total amount of 6PMF in the composition containing black ginger extract is determined as 100 parts by mass, an amount of 5-hydroxy-7-methoxyflavone in the composition containing black ginger extract is 5 parts by mass or less. When absorbance of an aqueous solution of the composition containing black ginger extract, in which a total amount of the 6 polymethoxyflavones is adjusted to a certain amount, is measured, the absorbance of the aqueous solution satisfies P1/V1≥1.45.
A61K 47/61 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
In an anti-metabolic syndrome agent, a whitening agent, an anti-aging agent, a hair growth tonic, an anti-inflammatory agent and a liver function-improving agent of the present invention, compounds 1-3 represented by general formula (I) are used as active ingredients. In an oral composition, skin cosmetic and hair cosmetic of the present invention, compounds 1-3 represented by general formula (I) are blended. The present invention can provide an anti-metabolic syndrome agent, a whitening agent, an anti-aging agent, a hair growth tonic, an anti-inflammatory agent and a liver function-improving agent each having excellent functional effects. Moreover, the present invention can provide an oral composition, a skin cosmetic and a hair cosmetic each being suitable for anti-metabolic syndrome, whitening, anti-aging, hair growth, anti-inflammatory and liver function-improving purposes.
This angiotensin-converting enzyme inhibitor and this blood pressure-lowering agent contain a compound represented by formula (I) as an active ingredient. These beverages and food products for inhibiting an angiotensin-converting enzyme and these beverages and food products for lowering blood pressure are characterized by containing a compound represented by formula (I). As a result, provided are an angiotensin-converting enzyme inhibitor and blood pressure-lowering agent that have an excellent angiotensin-converting enzyme-inhibiting effect and blood pressure-lowering effect. Furthermore, provided are beverages and food products suitable for inhibition of an angiotensin-converting enzyme and lowering of blood pressure.
This angiotensin-converting enzyme inhibitor and this blood pressure-lowering agent contain a compound represented by formula (I) as an active ingredient. These beverages and food products for inhibiting an angiotensin-converting enzyme and these beverages and food products for lowering blood pressure are characterized by containing a compound represented by formula (I). As a result, provided are an angiotensin-converting enzyme inhibitor and blood pressure-lowering agent that have an excellent angiotensin-converting enzyme-inhibiting effect and blood pressure-lowering effect. Furthermore, provided are beverages and food products suitable for inhibition of an angiotensin-converting enzyme and lowering of blood pressure.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Industrial chemicals; chemicals for use in industry and science; chemical products, namely, chemicals for use in the manufacture of foods, dietary supplements, pharmaceuticals and cosmetics; chemicals for use in the manufacture of foods, namely, as food ingredients; chemicals for use in the manufacture of cosmetics, namely, as cosmetic ingredients
19.
COMPOSITION CONTAINING BLACK GINGER EXTRACT AND COMPOSITION FOR ORAL ADMINISTRATION
This composition containing black ginger extract comprises a black ginger extract and cyclodextrin, wherein: when the total amount of specific six types of polymethoxyflavone (6PMF) in the composition containing black ginger extract is set to 100 parts by mass, the 5-hydroxy-7-methoxyflavone content of the composition containing black ginger extract is no more than 5 parts by mass; and the absorbance of an aqueous solution of the composition containing black ginger extract with the total amount of the 6PMF adjusted to a specific quantity fulfills the condition P1 / V1 ≥ 1.45.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
This angiotensin-converting enzyme inhibitor and this blood pressure-lowering agent contain a compound represented by formula (I) as an active ingredient. These beverages and food products for inhibiting an angiotensin-converting enzyme and these beverages and food products for lowering blood pressure are characterized by containing a compound represented by formula (I). As a result, provided are an angiotensin-converting enzyme inhibitor and blood pressure-lowering agent that have an excellent angiotensin-converting enzyme-inhibiting effect and blood pressure-lowering effect. Furthermore, provided are beverages and food products suitable for inhibition of an angiotensin-converting enzyme and lowering of blood pressure.
Provided is a composition which contains (A) a glycyrrhetinic acid derivative, (B) a polyethylene glycol monostearate, (C) a polyoxyethylene polyoxypropylene glyceryl ether, (D) a polyhydric alcohol, and (E) water. The composition is not turbid and is sediment-free.
A61K 47/14 - Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
An O/D-type emulsion composition containing glycyrrhetinic acid, the emulsion composition comprising (a) an oil comprising at least one of a higher alcohol and an ester oil, (b) a nonionic surfactant and (c) a polyhydric alcohol, wherein the ratio of the content of the nonionic surfactant (b) to the content of the oil (a), i.e., (b)/(a), is 0.26 to 3.5, the ratio of the content of the polyhydric alcohol (c) to the content of the nonionic surfactant (b), i.e., (c)/(b), is 0.75 to 6, and the content of water (d) is 0 to 15% by mass. The present invention also provides: a method for producing an O/D-type emulsion composition; an oil-in-water-type emulsion composition containing an O/D-type emulsion composition and a method for producing the oil-in-water-type emulsion composition; and an external preparation for skin, comprising an O/D-type emulsion composition or an oil-in-water-type emulsion composition. According to the O/D-type emulsion composition of the present invention, it becomes possible to produce an oil-in-water-type emulsion composition having glycyrrhetinic acid stably dispersed therein by adding a water-based medium to the O/D-type emulsion composition.
An antiaging agent that comprises, as an active ingredient, at least one of a fermented liquid of an Artemisia plant, a fermented liquid of Thymus vulgaris, a fermented liquid of Melissa officinalis and a fermented liquid of Centaurea cyanus; an antioxidant that comprises, as an active ingredient, at least one of a fermented liquid of an Artemisia plant, a fermented liquid of Thymus vulgaris, a fermented liquid of Melissa officinalis and a fermented liquid of Centaurea cyanus; an antiinflammatory agent that comprises, as an active ingredient, at least one of a fermented liquid of an Artemisia plant and a fermented liquid of Melissa officinalis; a whitening agent that comprises, as an active ingredient, at least one of a fermented liquid of an Artemisia plant, a fermented liquid of Melissa officinalis and a fermented liquid of Centaurea cyanus; and a cosmetic.
Malva mauritiana LArnicaArnica extract, eucalyptus extract, and royal jelly extract; (B-2) noni fruit juice and lemon juice; and (B-3) conchiolin hydrolysate and silk hydrolysate.
A61K 8/98 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution of animal origin
A61K 47/42 - ProteinsPolypeptidesDegradation products thereofDerivatives thereof, e.g. albumin, gelatin or zein
A61K 47/46 - Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
A61K 31/195 - Carboxylic acids, e.g. valproic acid having an amino group
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Industrial chemicals; chemicals for use in industry and science; chemical products, namely, chemicals for use in the manufacture of cosmetics and pharmaceuticals; chemicals for use in the manufacture of cosmetics, namely, as cosmetic ingredients; chemicals for manufacture of cosmetics, mainly composed of yeast extracts
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Industrial chemicals; chemicals for use in industry and science; chemical products, namely, chemicals for use in the manufacture of cosmetics and pharmaceuticals; chemicals for use in the manufacture of cosmetics, namely, as cosmetic ingredients
According to the present invention, an external preparation is configured to contain (A) one or more substances that are selected from among tranexamic acid, tranexamic acid derivatives and salts of tranexamic acid or tranexamic acid derivatives, and (B) one or more substances that are selected from among arginine, aspartic acid, glutamic acid, glycine, proline, serine, threonine, γ-aminobutyric acid, derivatives of these compounds, and salts of these compounds or the derivatives of these compounds, thereby being capable of suppressing crystallization of tranexamic acid.
Provided are: a damage recovery agent which is for making a recovery from damage caused to the hair and/or skin due to chlorine, and which contains a peach extract; and a hair and/or skin cosmetic which is used to make a recovery from damage caused to the hair and/or skin due to chlorine, and which contains the damage recovery agent.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Industrial chemicals; chemicals for use in industry and science; chemical products, namely, chemicals for use in the manufacture of cosmetics and pharmaceuticals; chemicals for use in the manufacture of cosmetics, namely, as cosmetic ingredients
30.
α GEL HAVING GLYCYRRHETINIC ACID DERIVATIVE AS STRUCTURAL COMPONENT, COMPOSITION CONTAINING α GEL, METHOD FOR PRODUCING α GEL, AND COSMETIC CONTAINING α GEL
Provided is a technique for forming an α gel having, as structural components: (A) a glycyrrhetinic acid derivative; (B) one or more selected from C14-18 aliphatic alcohols and fatty acids; (C) one or more selected from anionic surfactants, cationic surfactants, non-ionic surfactants, and amphoteric surfactants; (D) dipropylene glycol; and (E) water, thereby enabling a glycyrrhetinic acid derivative to be added to a dosage form that has a high water content and promoting the transdermal absorption of a glycyrrhetinic acid derivative.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Industrial chemicals; chemicals for use in industry and
science; chemical products for use in the manufacture of
cosmetics and pharmaceuticals; chemicals used as cosmetic
ingredients.
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
Industrial chemicals; chemicals for use in industry and science; Chemical products, namely, chemicals for use in the manufacture of cosmetics and pharmaceuticals; Chemicals for use in the manufacture of cosmetics, namely, as cosmetic ingredients
01 - Chemical and biological materials for industrial, scientific and agricultural use
Goods & Services
chemicals for use in industry and science; chemical additives for use in the manufacture of food; chemical additives for use in the manufacture of dietary supplements for humans
34.
Salt-free miso production method, salt-free miso, hepatic function improvement agent, and hypertension improvement agent
Provided are: a production method for salt-free miso, in which steamed soy beans and koji are pressurized, heated, and fermented; salt-free miso obtained by said production method; and a hepatic function improvement agent and a hypertension improvement agent that contain said salt-free miso as an effective component thereof.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
Provided are: a production method for salt-free miso, in which steamed soy beans and koji are pressurized, heated, and fermented; salt-free miso obtained by said production method; and a hepatic function improvement agent and a hypertension improvement agent that contain said salt-free miso as an effective component thereof.
A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (Republic of Korea)
MARUZEN PHARMACEUTICALS CO, LTD. (Japan)
Inventor
Hwang, Jae-Kwan
Sa, Bo Kyung
Kim, Tae Yoon
Abstract
The present invention relates to a pharmaceutical composition containing Kaempferia parviflora Wall. Ex. Baker extracts for treating muscle diseases, and more specifically to a pharmaceutical composition containing, as an active ingredient, Kaempferia parviflora Wall. Ex. Baker extracts or flavone compound isolated therefrom for treating muscle diseases or a dietary composition for improving muscle function. Kaempferia parviflora Wall. Ex. Baker extracts or flavone compound isolated therefrom according to the present invention reduces protein catabolism in the muscles and increases muscle cell differentiation and anbolism, and is thus effective for producing pharmaceutical composition for treating muscle diseases and dietary composition for improving muscle function.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/35 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
A61P 21/04 - Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
37.
Tie2 ACTIVATOR, VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, ANTI-ANGIOGENIC AGENT, AGENT FOR MATURING BLOOD VESSELS, AGENT FOR NORMALIZING BLOOD VESSELS, AGENT FOR STABILIZING BLOOD VESSELS, AND PHARMACEUTICAL COMPOSITION
[Problem] To provide: a Tie2 activator, a vascular endothelial growth factor (VEGF) inhibitor, an anti-angiogenic agent, an agent for maturing blood vessels, an agent for normalizing blood vessels and an agent for stabilizing blood vessels, which are highly safe and respectively have excellent Tie2 activating effect, vascular endothelial growth factor (VEGF) inhibitory effect, anti-angiogenic effect, blood vessel maturing effect, blood vessel normalizing effect and blood vessel stabilizing effect; and a pharmaceutical composition. [Solution] A Tie2 activator, a vascular endothelial growth factor (VEGF) inhibitor, an anti-angiogenic agent, an agent for maturing blood vessels, an agent for normalizing blood vessels and an agent for stabilizing blood vessels, each of which contains, as an active ingredient, at least one extract selected from among a hawthorn extract, a star fruit extract, a light galangal extract, an Indian lotus extract, a rooibos extract, an Indian date extract, a Chinese quince extract, a Psidium guava extract, a long pepper extract, a quillai extract, a kohki extract, a ginkgo extract, an oyster extract, a turmeric extract, a chrysanthemum extract, a jujube extract, a wolfberry extract, a chamomile extract and a butcher's broom extract; and a pharmaceutical composition.
A61K 36/73 - Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A skin-whitening agent or an anti-aging agent comprising at least one member selected from an extract from Myrica cerifera, an extract from Iris vesicolor, an extract from Piper kadzura, an extract from Primula veris, an extract from Aloysia triphylla, an extract from Agrimonia pilosa, an extract from Vaccinium spp., an extract from Apium graveolens, an extract from Tamarix tenuissima and an extract from Passiflora edulis.
A61K 8/97 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from algae, fungi, lichens or plantsCosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution from derivatives thereof
A61Q 19/02 - Preparations for care of the skin for chemically bleaching or whitening the skin
The object aims to find a substance having a glutathione production-enhancing activity among highly safe natural substances and to provide a glutathione production enhancer and a prophylactic/therapeutic agent for diseases associated with the lack of glutathione each of which comprises the substance as an active ingredient. The glutathione production enhancer or the prophylactic/therapeutic agent for diseases associated with the lack of glutathione comprises, as an active ingredient, a licorice extract composition which contains liquiritin, liquiritigenin, isoliquiritin and isoliquiritigenin but does not substantially contain glycyrrhetinic acid.
A61K 31/382 - Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
A61K 31/7034 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61P 1/04 - Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
A61P 1/16 - Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
A61P 11/00 - Drugs for disorders of the respiratory system
A61P 13/12 - Drugs for disorders of the urinary system of the kidneys
A61P 25/00 - Drugs for disorders of the nervous system
A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P 43/00 - Drugs for specific purposes, not provided for in groups
40.
REDUCED CHALCONE COMPOUND AND METHOD OF PRODUCING THE SAME, REDUCED PRODUCT OF FAT-SOLUBLE LICORICE ROOT EXTRACT AND METHOD OF PRODUCING THE SAME, CYCLOOXYGENASE-2 ACTIVITY INHIBITOR, WHITENING AGENT, ANTIINFLAMMATORY AGENT AND COSMETIC
It is intended to provide a reduced chalcone compound represented by the following structural formula (1), and a whitening agent, an antiinflammatory agent and a cosmetic containing this reduced chalcone compound. Structural formula (1) In the above structural formula (1), R1 represents an oxygen atom, a hydroxyl group or a hydrogen atom. R2 represents a hydrogen atom, a hydroxyl group or an alkyl group. R3 represents a hydrogen atom or a hydroxyl group. R4 represents a hydrogen atom, a hydroxyl group or an alkoxy group. R5 represents a hydrogen atom, a hydroxyl group or an alkylene group.
C07C 43/23 - Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
A61K 8/00 - Cosmetics or similar toiletry preparations
A61K 8/30 - Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
A61K 8/96 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution
A61K 31/085 - Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 36/48 - Fabaceae or Leguminosae (Pea or Legume family)CaesalpiniaceaeMimosaceaePapilionaceae
A61Q 19/02 - Preparations for care of the skin for chemically bleaching or whitening the skin
C07C 41/44 - SeparationPurificationStabilisationUse of additives by treatment giving rise to a chemical modification
C07C 45/85 - SeparationPurificationStabilisationUse of additives by treatment giving rise to a chemical modification
C07C 49/84 - Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
01 - Chemical and biological materials for industrial, scientific and agricultural use
29 - Meat, dairy products, prepared or preserved foods
30 - Basic staples, tea, coffee, baked goods and confectionery
Goods & Services
Natural plant extracts for use as ingredients in the
manufacture of pharmaceuticals, food, beverages, cosmetics
and toiletry preparations; animal extracts for use as
ingredients in the manufacture of pharmaceuticals, food,
beverages, cosmetics and toiletry preparations; marine
product extracts for use as ingredients in the manufacture
of pharmaceuticals, food, beverages, cosmetics and toiletry
preparations; seaweed extracts for use as ingredients in the
manufacture of pharmaceuticals, food, beverages, cosmetics
and toiletry preparations; fermented product extracts for
use as ingredients in the manufacture of pharmaceuticals,
food, beverages, cosmetics and toiletry preparations;
anti-oxidants for food, beverages, cosmetics and toiletry
preparations; emulsifiers for food, beverages, cosmetics and
toiletry preparations; chemicals used in industry,
photography and agriculture; manures; chemical substances
for preserving foodstuffs; artificial sweeteners; natural
plant extracts for use as surfactants, sweetening agents,
corrigents, emulsifier, stabilizer and gelatinizer; marine
product extracts for use as surfactants, sweetening agents,
corrigents, emulsifier, stabilizer and gelatinizer. Meat; fish; poultry and game; meat extracts; preserved,
dried and cooked fruits and vegetables; jellies; jams;
compotes; eggs; milk and milk products. Tea; seasonings and condiments; spices; flavor enhancer for
food; natural sweeteners; coffee; cocoa; sugar; rice;
tapioca; sago; artificial coffee; flour and preparations
made from cereals; bread; pastry and confectionery; ices;
honey; treacle; yeast; baking powder; salt; mustard;
vinegar; sauces; ice.
01 - Chemical and biological materials for industrial, scientific and agricultural use
29 - Meat, dairy products, prepared or preserved foods
30 - Basic staples, tea, coffee, baked goods and confectionery
Goods & Services
Natural plant extracts for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; animal extracts for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; marine animal extracts for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; seaweed extracts for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; fermented plant extracts and natural biological substances produced by fermentation using microorganisms for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; anti-oxidants for non-nutritional purposes for use in food, beverages, cosmetics and toiletry preparations; emulsifiers for food, beverages, cosmetics and toiletry preparations; artificial sweeteners; natural plant extracts for use as surfactants, sweetening agents, corrigents, emulsifier, stabilizer and gelatinizer; marine product extracts for use as surfactants, sweetening agents, corrigents, emulsifier, stabilizer and gelatinizer Meat extracts; preserved, dried and cooked fruits and vegetables Tea; seasonings and condiments, namely, [ mustard, ketchup, sauces, fish sauce, soybean sauce, vinegar, salt, powdered chilly, sugar, honey, ] flavorings other than essential oils, seasonings made from oyster extract, shitake mushroom extract, or crab extract; spices; flavor enhancer for food; natural sweeteners
01 - Chemical and biological materials for industrial, scientific and agricultural use
29 - Meat, dairy products, prepared or preserved foods
30 - Basic staples, tea, coffee, baked goods and confectionery
Goods & Services
Natural plant extracts for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; animal extracts for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; marine product extracts for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; seaweed extracts for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; fermented product extracts for use as ingredients in the manufacture of pharmaceuticals, food, beverages, cosmetics and toiletry preparations; anti-oxidants for food, beverages, cosmetics and toiletry preparations, emulsifiers for food, beverages, cosmetics and toiletry preparations; chemicals used in industry, photography and agriculture; manures; chemical substances for preserving foodstuffs. Natural plant extracts for use as food additives; marine product extracts for use as food additives; meat, fish, poultry and game; meat extracts; preserved, dried and cooked fruits and vegetables; jellies, jams, compotes; eggs, milk and milks products. Tea; seasonings and condiments; spices; flavor enhancer; natural sweeteners; coffee; cocoa; sugar; rice; tapioca; sago; artificial coffee; flour and preparations made from cereals; bread, pastry and confectionery; ices; honey; treacle; yeast; baking powder; salt; mustard; vinegar; sauces; ice.
